Molecule Structure

Scientific Name

Meclizine

Description of the Drug

Meclizine is a histamine H1 antagonist used to treat nausea, vomiting, and dizziness associated with motion sickness.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00737

Brand Name(s)

Not Available

Company Owner(s)

Invagen Pharmaceuticals Inc, Cm Bundy Co, Kv Pharmaceutical Co, Watson Laboratories Inc, Nexgen Pharma Inc, Amneal Pharmaceuticals Of New York Llc, Anabolic Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Udl Laboratories Inc, Rising Pharma Holdings Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Histamine H1 receptor SINGLE PROTEIN ANTAGONIST CHEMBL231

Unichem Links

SureChEMBL SCHEMBL4649
PharmGKB PA450338
Human Metabolome Database HMDB0014875
DrugBank DB00737
PubChem: Thomson Pharma 14805236
PubChem 4034
Mcule MCULE-7463916552
LINCS LSM-1607
Nikkaji J6.532C
BindingDB 81467
EPA CompTox Dashboard DTXSID0023242
DrugCentral 1649
Brenda 243513
Guide to Pharmacology 2757
rxnorm MECLIZINE HYDROCHLORIDE MECLIZINE ANTIVERT
KEGG Ligand C07116
ChEBI 6709